Medtronic (NYSE:MDT) is laying off 81 employees at its Northridge, California diabetes device facility, effective April 7, 2026. This restructuring comes as the company prepares to spin out its diabetes business, MiniMed, into a standalone public entity. The affected roles include engineering, IT, marketing, and technician positions, with Medtronic stating the cuts are necessary to ensure the new company’s long-term success.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Medtronic to cut 81 employees at California diabetes site
Medtronic (NYSE:MDT) is laying off 81 employees at its Northridge, California diabetes device facility, effective April 7, 2026. This restructuring comes as the company prepares to spin out its diabetes business, MiniMed, into a standalone public entity. The affected roles include engineering, IT, marketing, and technician positions, with Medtronic stating the cuts are necessary to ensure the new company’s long-term success.